Fatty acids and osteoarthritis: different types, different effects.


Journal

Joint bone spine
ISSN: 1778-7254
Titre abrégé: Joint Bone Spine
Pays: France
ID NLM: 100938016

Informations de publication

Date de publication:
07 2019
Historique:
received: 30 04 2018
accepted: 20 07 2018
pubmed: 7 8 2018
medline: 29 2 2020
entrez: 7 8 2018
Statut: ppublish

Résumé

While the association between obesity and osteoarthritis used to be solely regarded as a result of increased mechanical loading, systemic factors also likely play a role in the pathophysiology of osteoarthritis. Nutrient excess leading to obesity may result in lipotoxicity, which might be involved in the development of osteoarthritis. The different fatty acid types have distinct effects on inflammation. This review focusses on the currently available studies, summarizing the effects of the different fatty acid types on osteoarthritis and involved joint tissues. In animal studies omega-3 polyunsaturated fatty acids reduced the expression of inflammatory markers, cartilage degradation and oxidative stress in chondrocytes. In contrast, these markers were increased upon omega-6 polyunsaturated fatty acid and saturated fatty acid stimulation. Additionally, a decrease in pain and dysfunction was observed upon omega-3 supplementation in cats and dogs. In line, most human in vitro studies show pro-apoptotic and pro-inflammatory actions of saturated fatty acids. While all polyunsaturated fatty acids reduced markers of oxidative stress, omega-3 polyunsaturated fatty acids additionally decreased prostaglandin production. Human intervention studies with omega-3 polyunsaturated fatty acid supplementation may indicate a beneficial effect on pain and function and might be associated with less structural damage. In contrast, an adverse effect of saturated fatty acids on osteoarthritis has been observed. Monounsaturated fatty acids have been infrequently studied and findings are inconclusive. Existing studies indicate a promising effect of especially omega-3 polyunsaturated fatty acids on osteoarthritis signs and symptoms. However, more human intervention studies are warranted to draw robust conclusions.

Identifiants

pubmed: 30081198
pii: S1297-319X(18)30182-9
doi: 10.1016/j.jbspin.2018.07.005
pii:
doi:

Substances chimiques

Biomarkers 0
Fatty Acids 0
Fatty Acids, Omega-3 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

451-458

Informations de copyright

Copyright © 2018 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Marieke Loef (M)

Department of rheumatology, C1-R, Leiden university medical center, 2300 RC Leiden, The Netherlands. Electronic address: m.loef@lumc.nl.

Jan W Schoones (JW)

enter, Leiden, The Netherlands.

Margreet Kloppenburg (M)

Department of rheumatology, C1-R, Leiden university medical center, 2300 RC Leiden, The Netherlands; Department of clinical epidemiology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.

Andreea Ioan-Facsinay (A)

Department of rheumatology, C1-R, Leiden university medical center, 2300 RC Leiden, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH